Ribociclib plus endocrine therapy in bone marrow visceral crisis: challenging the chemotherapy paradigm in luminal metastatic breast cancer-a case report.

Front Oncol · 2025 · PMC12753461 · PMID 41479780

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

7.8 months with chemotherapy; HR 0.45) and time to treatment failure, with a numerical trend toward improved overall survival.

also in 669 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.